We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma

This study has been terminated.
(Manufacturer stopped drug development)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00511043
First Posted: August 3, 2007
Last Update Posted: December 9, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
David Rizzieri, MD, Duke University Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2010
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: September 7, 2012